This is how you help get favorable government pressure on insurance to mandate coverage. You create this interwoven connection of jobs, government investment, and cancer treatment, so then if the insurance companies start denying proton coverage, you then appeal to the legislature that not only is this hurting your patients, but it's hurting the economy and jobs, so it's even more reason to force them to cover protons.
I'm not sure what will come of all this, but if the phase III prostate trial and the phase III lung trial are negative trials, then look out. However, if they're positive trials, then the gamble will have been worth it.